HQY HEALTHEQUITY, INC.
Services-Business Services, NEC · Nasdaq · SEC CIK 1428336 · Fiscal year ends 01/31
Financial factors as of 2026-07-31 (2027Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY7.3%
TTM net income YoY62.2%
TTM EPS YoY67.9%
Revenue 3-yr CAGR13.2%
Net income 3-yr CAGR164.2%
Margins
Gross margin71.2%
Operating margin25.8%
Net margin17.4%
FCF margin35.8%
EBITDA margin31.5%
Returns
ROE11.4%
ROA7.1%
ROIC (approx.)9.8%
Asset turnover0.41x
Leverage & solvency
Liabilities / assets39.2%
Debt / equity0.47x
Current ratio2.99x
Interest coverage6.69x
Cash quality & payout
Operating cash flow / net income2.07x
Accruals ratio-7.6%
Payout ratio—
Capex / revenue0.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2027Q22026-07-31 | 2027Q12026-04-30 | 2026Q4*2026-01-31 | 2026Q32025-10-31 | 2026Q22025-07-31 | 2026Q12025-04-30 | 2025Q4*2025-01-31 | 2025Q32024-10-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $350.73M | $354.64M | $334.59M | $322.16M | $325.83M | $330.84M | $311.82M | $300.43M |
| Cost of revenue | $92.78M | $98.33M | $106.44M | $94.10M | $93.24M | $106.53M | $122.77M | $103.41M |
| Gross profit | $257.95M | $256.31M | $228.15M | $228.06M | $232.59M | $224.31M | $189.04M | $197.03M |
| R&D expense | $73.92M | $67.77M | $70.35M | $65.92M | $64.80M | $61.44M | $64.65M | $60.19M |
| SG&A expense | $34.87M | $31.13M | $33.53M | $30.88M | $29.99M | $25.54M | $29.98M | $31.79M |
| Operating income | $98.69M | $102.95M | $71.07M | $78.69M | $89.61M | $83.08M | $42.15M | $19.62M |
| Interest expense | $12.61M | $12.59M | $13.27M | $14.05M | $14.96M | $14.86M | $15.26M | $18.16M |
| Pretax income | $87.86M | $92.41M | $60.90M | $67.53M | $78.05M | $70.95M | $29.96M | $6.22M |
| Income tax | $22.22M | $23.00M | $11.16M | $15.84M | $18.19M | $17.04M | $3.60M | $515,000 |
| Net income | $65.64M | $69.42M | $49.74M | $51.69M | $59.85M | $53.91M | $26.36M | $5.70M |
| EBITDA | $99.19M | $141.17M | $109.75M | $79.09M | $90.11M | $121.82M | $81.33M | $20.62M |
| EPS (basic) | 0.79 | 0.82 | — | 0.60 | 0.69 | 0.62 | — | 0.07 |
| EPS (diluted) | 0.78 | 0.82 | — | 0.59 | 0.68 | 0.61 | — | 0.06 |
| Weighted avg. shares (diluted) | 84.01M | 85.01M | — | 86.97M | 87.75M | 88.42M | — | 88.63M |
| Balance sheet | ||||||||
| Cash & equivalents | $256.00M | $265.37M | $318.93M | $309.26M | $304.46M | $287.89M | $295.95M | $322.16M |
| Receivables | $122.19M | $122.00M | $123.70M | $111.24M | $111.16M | $116.26M | $118.01M | $106.71M |
| Current assets | $460.20M | $466.53M | $512.28M | $498.71M | $492.83M | $472.80M | $477.75M | $495.25M |
| PP&E, net | $4.82M | $3.80M | $3.18M | $3.39M | $3.09M | $3.17M | $3.24M | $3.89M |
| Goodwill | $1.65B | $1.65B | $1.65B | $1.65B | $1.65B | $1.65B | $1.65B | $1.65B |
| Intangibles | $1.05B | $1.07B | $1.10B | $1.12B | $1.15B | $1.18B | $1.20B | $1.23B |
| Total assets | $3.27B | $3.31B | $3.38B | $3.40B | $3.42B | $3.42B | $3.45B | $3.49B |
| Current liabilities | $153.78M | $135.74M | $156.85M | $120.63M | $116.58M | $116.34M | $156.32M | $154.54M |
| Short-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term debt | $931.06M | $942.66M | $957.38M | $982.11M | $1.01B | $1.06B | $1.06B | $1.08B |
| Total debt | $931.06M | $942.66M | $957.38M | $982.11M | $1.01B | $1.06B | $1.06B | $1.08B |
| Total liabilities | $1.28B | $1.26B | $1.27B | $1.26B | $1.27B | $1.29B | $1.33B | $1.36B |
| Shareholders' equity | $1.99B | $2.05B | $2.11B | $2.13B | $2.15B | $2.12B | $2.11B | $2.12B |
| Net debt | $675.06M | $677.29M | $638.45M | $672.85M | $702.37M | $768.67M | $760.35M | $758.88M |
| Shares outstanding | 82.91M | 83.93M | 85.01M | 85.61M | 86.42M | 86.71M | 86.54M | 86.82M |
| Cash flow statement | ||||||||
| Operating cash flow | $136.16M | $97.53M | $117.92M | $138.57M | $135.87M | $64.74M | $75.75M | $90.55M |
| Capital expenditure | $978,000 | $362,000 | $326,000 | $784,000 | $773,000 | $86,000 | $328,000 | $294,000 |
| Free cash flow | $135.18M | $97.16M | $117.59M | $137.79M | $135.09M | $64.65M | $75.42M | $90.26M |
| Investing cash flow | -$25.91M | -$13.90M | -$8.44M | -$11.38M | -$11.18M | -$16.14M | -$13.56M | -$12.87M |
| Financing cash flow | -$119.61M | -$137.18M | -$99.81M | -$122.40M | -$108.12M | -$56.65M | -$88.41M | -$82.42M |
| Depreciation & amortization | $500,000 | $38.21M | $38.68M | $400,000 | $500,000 | $38.74M | $39.18M | $1.00M |
| Stock-based compensation | $22.21M | $19.41M | $19.12M | $20.54M | $19.07M | $14.34M | $21.71M | $21.12M |
| Share buybacks | $107.74M | $123.31M | $81.02M | $92.42M | $66.75M | $59.06M | $62.98M | $58.51M |
Free plan shows the latest 8 periods; Pro shows all 54 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.